Published on
On October 25th, self-advocate David Egan, Chair of the National Down Syndrome Society’s Scientific and Clinical Advisory Board, Dr. William Mobley, NDSS President & CEO, Kandi Pickard, and a coalition of Down syndrome organizations delivered comments to the National Alzheimer’s Project Act (NAPA) Advisory Council on several issues that the Down syndrome community faces when it comes to Alzheimer’s disease. View the comments below: